Sofinnova Investments
Overview
Sofinnova Investments is a healthcare investment firm that partners with entrepreneurs to fund and build innovative biopharmaceutical companies across all stages of development.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Principia | Apr 2014 | Series B | Lead |
| Jade Biosciences, Inc. | Aug 2020 | Series A | Lead |
| NexCure, Inc. | Nov 2019 | Follow-on Offering | Co-investor |
| BioAge Labs | Sep 2024 | Private Placement | Lead |
| Bolt Biotherapeutics | Jul 2020 | Series C | Lead |
For institutional investors. Book with your work email.
Key People
James H.
Managing Partner
Eric Delbridge
General Partner
Maha Katabi
General Partner
Sarah Bhagat
General Partner
Goro Takeda
Venture Partner
Aneal Tenjarla
Associate Portfolio Manager, Partner
Chris Carpenter
Executive Partner
Jakob Dupont
Executive Partner
Jonathan Leff
Executive Partner
Lars Ekman
Excecutive Partner
Perry Nisen
Executive Partner
Remy Aubert
Partner
Nathalie Auber
Partner And CFO
Nick Lenard
Healthcare Investor
Peng Li
Healthcare Investor
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Sofinnova Investments based?
Sofinnova Investments is headquartered in Menlo Park, California, United States.
When was Sofinnova Investments founded?
Sofinnova Investments was founded in 1976.
How many portfolio companies does Sofinnova Investments have?
Sofinnova Investments has 44 portfolio companies in Caplight's dataset.
What are some companies in Sofinnova Investments's portfolio?
Portfolio companies visible on Caplight include Principia, Jade Biosciences, Inc., NexCure, Inc., BioAge Labs, Bolt Biotherapeutics.
What was Sofinnova Investments's most recent investment shown here?
Sofinnova Investments's most recent investment in this portfolio sample was in BioAge Labs in 2024.
What sectors does Sofinnova Investments focus on?
Sofinnova Investments focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Media, Entertainment & Gaming, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Consumer & Commerce, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, Healthcare & Life Sciences, Frontier & Industrial Tech, Healthcare & Life Sciences, Enterprise Software, AI, Data & Cloud Infrastructure, AI, Data & Cloud Infrastructure.
What company stages does Sofinnova Investments focus on?
Sofinnova Investments typically invests at the MultiStage stage.
What is Sofinnova Investments's AUM?
Sofinnova Investments's assets under management are estimated between $1.0B and $10.0B.